Baudax Bio Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2022	2021	2020	2019	2018	2017
Revenue	1.27	1.08	0.49	0	0	0
Revenue Growth (YoY)	17.50%	119.07%	-	-	-	-
Cost of Revenue	7.01	2.45	1.73	0	0	0
Gross Profit	-5.74	-1.37	-1.24	0	0	0
Selling, General & Admin	24.12	45.31	43.34	27.01	29.45	19.63
Research & Development	3.89	3.13	9.09	20.06	35.58	28.64
Other Operating Expenses	25.84	2.58	2.15	0	0	0
Operating Expenses	53.84	51.01	54.57	47.07	65.04	48.26
Operating Income	-59.58	-52.38	-55.81	-47.07	-65.04	-48.26
Interest Expense / Income	0	0	1.36	0	0	0
Other Expense / Income	-0.79	-32.61	18.93	-14.52	8.63	12.82
Pretax Income	-58.8	-19.77	-76.1	-32.56	-73.67	-61.08
Net Income	-58.8	-19.77	-76.1	-32.56	-73.67	-61.08
Shares Outstanding (Basic)	0	0	0	0	0	-
Shares Outstanding (Diluted)	0	0	0	0	0	-
Shares Change	505.82%	311.07%	99.37%	-	-	-
EPS (Basic)	-177.30	-361.16	-5714.80	-4872.01	-11032.01	-
EPS (Diluted)	-177.30	-361.16	-5714.80	-4872.01	-11032.01	-
Free Cash Flow	-27.81	-49.47	-44.7	-51.53	-63.2	-44.56
Free Cash Flow Per Share	-83.87	-903.82	-3356.64	-7714.85	-9462.84	-
Gross Margin	-452.32%	-126.39%	-251.32%	-	-	-
Operating Margin	-4695.11%	-4849.63%	-11319.88%	-	-	-
Profit Margin	-4633.18%	-1830.46%	-15436.11%	-	-	-
Free Cash Flow Margin	-2191.73%	-4580.83%	-9066.33%	-	-	-
EBITDA	-56.63	-16.95	-72.19	-32.08	-73.27	-61.01
EBITDA Margin	-4462.81%	-1569.72%	-14642.39%	-	-	-
Depreciation & Amortization	2.16	2.82	2.55	0.48	0.4	0.07
EBIT	-58.8	-19.77	-74.74	-32.56	-73.67	-61.08
EBIT Margin	-4633.18%	-1830.46%	-15160.45%	-	-	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).